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ABSTRACT
Insulin is a high-alert medication in both
inpatient and outpatient settings. Insulin can
cause significant harm when administered in
error. Despite advancements in insulin pen
technology, errors in the administration tech-
nique remain an issue. Although various factors
can contribute to administration errors, lack of
education on how to operate these devices is
one of the most common reasons they occur. As
such, the mechanical technique used by the
patient needs to be continually assessed in order
to reinforce education where needed. We
describe three unique patient cases that depict
incorrect administration techniques when
using pen devices and the consequences that
could have resulted from these errors. These
cases involve the use of a syringe instead of a
pen needle, injecting without removing the
inner cap, and dialing the pen back down
instead of pushing the plunger. Although pen
devices are relatively simple to use, this article
reinforces the need for continual assessment of
and education about insulin administration.
The teach-back method is an approach that can
be used to assess a patient’s technique and
re-educate them at every available opportunity
to reduce the risk of administration errors,
which can result in complications and
hospitalizations.
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INTRODUCTION
Among the many people who have diabetes,
approximately 6 million use insulin to control
their blood glucose [1]. In ten years, the use of
insulin in conjunction with oral therapy has
increased from 11.5% to 13.0% [2], likely due to
its earlier introduction during the course of
treatment for those with type 2 diabetes. This
keeps insulin consistently in the top 200 dis-
pensed medications in the United States [3].
Correct administration of insulin is essential
since employing an incorrect technique may
lead to hyperglycemic crisis or severe hypo-
glycemia, necessitating emergency department
(ED) visits. Geller et al. used national surveil-
lance data and estimated that 97,648 ED visits
occur annually due to insulin-related hypo-
glycemia, with almost one-third resulting in
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hospital admission. They also found that severe
neurologic sequelae occurred in 60.6% of these
visits, and blood glucose levels of less than
50 mg/dL were documented in 53.4% of the
cases [4]. More broadly, according to the
American Diabetes Association, about 282,000
ED visits in 2011 were due to hypoglycemia,
and approximately 175,000 ED visits were due
to a hyperglycemic crisis [1].
Due to these risks, insulin is continually lis-
ted on the Institute for Safe Medication Prac-
tice’s (ISMP’s) list of high-alert medications in
both acute care settings and community/am-
bulatory care settings [5]. The ISMP high-alert
medications are those that can cause significant
harm, including death, to a patient when used
in error [5]. Insulin errors can occur at each step
of the medication use process, including pre-
scribing, transcribing, dispensing, and admin-
istration. The majority of these errors occur
during administration [6].
Historically, insulin was injected using only
vial and syringe. This method continues to be
used today, albeit at a much lower rate. Today,
more than 60% of insulin users worldwide are
using insulin pen devices to administer insulin
[7]. Compared to vial and syringe, insulin pens
tend to be more accurate, more comfortable,
less obtrusive, and easier and more convenient
to use due to advances in the technology [8–13].
These technological advances have resulted in
increased patient preference of these devices,
improved insulin adherence, enhanced quality
of life, and decreased overall health care costs
[10–14]. Despite these improvements, the way
in which they are operated by patients needs to
be assessed in order to identify areas in which
education should be reinforced.
Here we present three patient cases in which
errors in insulin pen technique and administra-
tion negatively impacted the patients’ diabetes
control and could have resulted in more serious
health issues. These types of insulin pen admin-
istration errors were previously unreported.
CASES
Case 1 A 44-year-old Caucasian male with type 1
diabetes presented to the pharmacotherapy
clinic for routine follow-up. While providing a
medication history, the patient reported that he
did not not like insulin pens. He stated, ‘‘I find
them to be a hassle compared to vial and syr-
inge.’’ In his electronic medical record, a
short-acting insulin pen device and 1/2 cc
insulin syringes were on his medication list, but
no insulin pen needles. When asked to
demonstrate his use of the insulin pen, he took
an insulin syringe, injected the syringe into his
pen device, dialed the device to 5 units and
pushed the plunger. He believed that he was
filling the insulin syringe with 5 units of insulin
by doing this, and then used the syringe to
inject his insulin, which was essentially empty.
Case 2 A 65-year-old African American
female diagnosed with type 2 diabetes pre-
sented to the pharmacotherapy clinic for initial
diabetes assessment. She was diagnosed
6 months prior to the visit with an A1C finding
of 14.8% (138 mmol/mol). Glipizide 5 mg daily
and insulin detemir flexpen 10 units twice daily
were started at diagnosis, and insulin detemir
had since been increased to 20 units in the
morning and 30 units in the evening while
glipizide remained at 5 mg daily. When asked if
the patient had any difficulty injecting the
insulin pen device, she reported that it ‘‘spills
out of the skin’’ before the entire dose is given.
Patient was then asked to demonstrate her
technique. She placed the pen needle on the
pen device and securely screwed it on. She
removed the outer cap of the needle, then dia-
led the device up to 20 units and attempted to
inject without removing the inner cap. Hence,
the needle was never injected and insulin flo-
wed out of the inner cap. Despite not receiving
any insulin for 6 months, her blood glucose
readings had dramatically improved and were at
goal with an updated A1C of 6.6%
(49 mmol/mol), likely due to extensive lifestyle
modifications and glipizide initiation. After this
discovery, insulin detemir was discontinued.
Blood glucose remained controlled for at least
12 months following its discontinuation.
Case 3 A 55-year-old Hispanic female with
type 2 diabetes presented to the pharma-
cotherapy clinic for routine follow-up regarding
bolus insulin initiation 2 weeks prior. She had
been on basal insulin via vial and syringe for a
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few years with insufficient results. Her primary
care provider initiated bolus insulin via pen
device for ease of use and transportation; how-
ever, no education was given on the injection
technique since the patient had previously
taken insulin. The patient reported that her
blood sugars were not improving and she wan-
ted to know how long each pen should last.
After visual inspection of the pen device, it was
evident that no insulin had been dispensed yet.
When asked to demonstrate her injection
technique, the patient properly placed the
needle on the device and dialed the dose to 10
units. She then removed the outer and inner
caps of the needle and inserted it. Instead of
pushing the plunger button to dispense the
medication, she dialed the dose down from 10
to 0 by twisting the end of the pen device as she
had been doing at home the previous 2 weeks.
Informed consent was obtained verbally
from the patients included in this manuscript.
DISCUSSION
The above cases expose the danger of incorrect
administration techniques. In the first case, the
patient with type 1 diabetes had essentially no
bolus coverage due to the inappropriate use of a
syringe instead of a pen needle, and was at risk
for diabetic ketoacidosis since patients with
type 1 diabetes lack endogenous insulin pro-
duction and rely on injectible insulin products.
Another concern over the use of a syringe and
withdrawing insulin from a pen is the evolution
of more concentrated insulins in pen form. This
particular patient had a U-100 formulation;
however, it highlights the importance of proper
education on pen use. In the second case, the
incorrect use of the insulin pen was, ironically,
advantageous to the patient, as her A1C had
reached the goal without her actually needing
to inject any insulin. Had she injected the
insulin correctly, the patient would have been
at risk for severe hypoglycemia. Similar to the
first case, the patient in case 3 was not injecting
any insulin at all due to incorrect technique.
The error was discovered and corrected quickly,
thereby limiting the risk of titrating the dose to
inadvertent nonadherence. In all three of these
cases, administration errors were discovered by
having the patient demonstrate how they
operated their pen device. These cases highlight
the importance of education on insulin
administration, assessing technique, and re-ed-
ucating in cases where understanding is lacking,
even with a product that is seemingly relatively
simple.
With over 1700 different types of devices
approved by the U.S. Food and Drug Adminis-
tration, ensuring that patients receive proper
education on the use of these devices is vital
[15]. The use of insulin has several components
that must be taught and learned, including
insulin storage and suspension, injection site
care, the injection process, insulin pen use, skin
folds, injection site rotation, and needle use and
length [16]. Other considerations that are
taught when using insulin include injection
complications, proper disposal of the injection
material, hypoglycemia, and monitoring [16].
The amount of information given to a patient
when initiating insulin likely results in an
inability to retain all of the information taught.
A cross-sectional study that aimed to identify
the most common incorrect self-administration
techniques for insulin found that 21% of par-
ticipants reported a lack of knowledge of the
steps involved in insulin administration: on
average, 61% of the steps were performed cor-
rectly [17]. Additionally, the Insulin Injection
Technique Questionnaire developed by De
Coninck et al. was used to query patients on
how they inject insulin. Several administration
errors were discerned, including injecting into
the same site, injecting into lipohypertrophic
lesions, needle reuse, injecting through clothes,
and not mixing cloudy insulins before use.
When asked why these errors occurred, many
patients reported they did not recall learning
the skills to inject insulin [18]. Whether
patients were not taught these skills or whether
they simply forgot due to the amount of infor-
mation given to them is unknown. Neverthe-
less, providers should assess administration
technique and repeat the education until
patients understand the standard technique and
why it matters. Nakatani et al. aimed to evaluate
the impact of re-education on insulin injection
technique in 87 insulin-treated patients. The
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results showed that there was a significant
decrease in HbA1c and glycoalbumin levels in
all 87 patients, with patients with a poor initial
understanding of the insulin injection tech-
nique gaining the most from the re-education
[19]. This study illustrates how important it is to
provide proper education, including re-educa-
tion, on the self-administration of insulin in
order to reduce medication errors and prevent
complications.
A fundamental approach to assessing insulin
administration technnique is the teach-back
method. The teach-back method is an inter-
vention that is used to assess learners’ skills and
understanding by having the patient explain to
the provider, in their own words, what they
learned after being introduced to the concept
for the first time. The teach-back method also
helps to assess the effectiveness of the educa-
tor’s ability to convey concepts to the learner
[20, 21]. It permits immediate remediation and
clarification of skills and concepts if they are
not properly understood. According to the
experiences of frontline pharmacists, more than
98% of the 66 patients in the study agreed that
they felt confident about performing subcuta-
neous insulin injections according to guidelines
after being instructed via the teach-back
method [21]. Indeed, the Institute for Ethics
and the Agency for Healthcare Research and
Quality promote the teach-back method as a
‘‘best practice’’ to enhance patient knowledge
and improve patient outcomes [22, 23].
CONCLUSIONS
Although pen devices have been shown to
provide greater accuracy and are associated with
greater treatment satisfaction, these cases
demonstrate that problems still exist, even with
a product that is seemingly relatively simple to
use. This article reinforces the need for repeated
patient education and assessment of insulin
administration. Patients must understand best
practices and why they matter in order to avoid
adverse effects of insulin. The teach-back
method is a fundamental approach in which
assessment and re-education is performed at
every available opportunity to reduce compli-
cations and hospitalization rates due to poor
injection technique.
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